A smartphone dongle for diagnosis of infectious diseases at the point of care
Citations Over TimeTop 1% of 2015 papers
Abstract
This work demonstrates that a full laboratory-quality immunoassay can be run on a smartphone accessory. This low-cost dongle replicates all mechanical, optical, and electronic functions of a laboratory-based enzyme-linked immunosorbent assay (ELISA) without requiring any stored energy; all necessary power is drawn from a smartphone. Rwandan health care workers used the dongle to test whole blood obtained via fingerprick from 96 patients enrolling into care at prevention of mother-to-child transmission clinics or voluntary counseling and testing centers. The dongle performed a triplexed immunoassay not currently available in a single test format: HIV antibody, treponemal-specific antibody for syphilis, and nontreponemal antibody for active syphilis infection. In a blinded experiment, health care workers obtained diagnostic results in 15 min from our triplex test that rivaled the gold standard of laboratory-based HIV ELISA and rapid plasma reagin (a screening test for syphilis), with sensitivity of 92 to 100% and specificity of 79 to 100%, consistent with needs of current clinical algorithms. Patient preference for the dongle was 97% compared to laboratory-based tests, with most pointing to the convenience of obtaining quick results with a single fingerprick. This work suggests that coupling microfluidics with recent advances in consumer electronics can make certain laboratory-based diagnostics accessible to almost any population with access to smartphones.
Related Papers
- → Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein(2003)41 cited
- Principles & practice of point-of-care testing(2002)
- → The Case for Point-of-Care Testing in Infectious-Disease Diagnosis(2007)8 cited
- Thrombosis and hemostasis testing at the point of care.(1995)
- → 3. Point of Care: Useful Clinical Examination and Ultrasonography, 1) Clinical Laboratory Test: Point of Care Testing, Cardiac Marker (Mainly Cardiac Troponin)(2019)